HSBC HOLDINGS PLC

Position in RIGL — Rigel Pharmaceuticals Inc

CIK 873630 LONDON, X0

Position in RIGL

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$726,732

+$351,931 QoQ

Shares Held

18,577

+34.0% QoQ

Ownership

0.099%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#75

of 156 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HSBC HOLDINGS PLC holds $1,221,504,678 across 135 Biotechnology names. RIGL ranks #59 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	676,247	$335,912,169
2	REGN	Regeneron Pharmaceuticals, Inc.	382,028	$238,209,735
3	INCY	Incyte Corp	1,307,743	$148,245,744
4	RPRX	Royalty Pharma plc	1,224,925	$68,681,542
5	MRNA	Moderna, Inc.	636,199	$44,553,014
6	ALNY	Alnylam Pharmaceuticals, Inc.	115,279	$34,702,435
7	INSM	INSMED Inc	279,961	$29,849,438
8	BMRN	Biomarin Pharmaceutical Inc	307,543	$17,597,610

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$726,732	18,577	+34.0%	Shares	Defined	2026-08-14
2026-03-31	$374,801	13,861	+11.4%	Shares	Defined	2026-04-30
2025-12-31	$532,976	12,444	+17.8%	Shares	Defined	2026-03-06
2025-09-30	$299,221	10,562	-87.5%	Shares	Defined	2025-11-13
2024-03-31	$125,542	84,826	+302.0%	Shares	Defined	2024-05-15
2023-12-31	$30,599	21,103	0.0%	Shares	Defined	2024-02-12
2023-09-30	$22,791	21,103	+0.6%	Shares	Defined	2023-11-13
2023-06-30	$27,053	20,972	0.0%	Shares	Defined	2023-08-11
2023-03-31	$27,683	20,972	-73.4%	Shares	Defined	2023-05-15
2021-03-31	$269,574	78,823	-59.0%	Shares	Defined	2021-05-14
2020-12-31	$673,564	192,447	-0.0%	Shares	Defined	2021-02-25
2020-09-30	$461,880	192,450	-11.1%	Shares	Defined	2020-11-12
2020-06-30	$396,345	216,582	+38.8%	Shares	Defined	2020-08-14
2020-03-31	$243,369	156,006	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.